Develops fungal consortia to enhance heavy oil degradation in soil, indicating their potential effectiveness for bioremediation.
Leveraging fungal consortia to degrade heavy oil is an emerging strategy for mitigating/cleaning up environmental pollution. However, many consortia are predominantly evaluated by measuring the biodegradation efficiency of heavy oil, with insufficient attention paid to the mechanistic underpinnings and metabolic pathways. In this study, heavy oil-degrading fungal consortia were developed for potential application in soil bioremediation. Whole-genome sequencing was used to predict the metabolic pathways and interspecific interactions driving heavy oil biodegradation. Three heavy oil-degrading fungal strains, designated Aspergillus corrugatus FH2, Aspergillus terreus FL4, and Alternaria alstroemeriae FW1, were isolated from oil sludge in the Karamay Oilfield in Xinjiang, China. Four consortia were constructed through the combination of two or three strains. The consortium F13 (FH2 + FW1) achieved 72.0% removal of heavy oil in a simulated bioremediation test over 30 days, which was more efficient than other consortia and single strains (59.5–68.5%). Notably, the mean degradation rate of long-chain alkanes (C24–C28) by F13 reached 95.9%. After F13 treatment, the major fractions of heavy oil showed considerable degradation, 87.4% for saturates, 92.0% for aromatics, 69.5% for resins, and 27.3% for asphaltenes. Genome annotation of FH2, FL4, and FW1 revealed the presence of core genes for degradation of n-alkanes and aromatics, e.g., CYP505, frmA, fadB, hmgA, ALDH, and ACSL. These functional genes encoded cross-lineage enzymes, enabling synergistic catabolism of C13–C28 alkanes and aromatics. Our findings indicated that the fungal consortium of A. corrugatus FH2 and Al. alstroemeriae FW1 has remarkable bioremediation potential for heavy oil-contaminated sites. This study provides molecular evidence for the design of targeted interventions to improve soil remediation efficiency with fungal consortia.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: